Alyeska Investment Group
XENT

Alyeska Investment Group’s Intersect ENT, Inc XENT Stock Holding History

Alyeska Investment Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,386
Closed -$574K – 473
2018
Q4 		$574K Buy
+20,386
New +$597K 0.01% 330
2015
Q3 		– Sell
-50,000
Closed -$1.43M – 552
2015
Q2 		$1.43M Buy
+50,000
New +$1.31M 0.02% 377
2014
Q4 		– Sell
-207,123
Closed -$3.21M – 548
2014
Q3 		$3.21M Buy
+207,123
New +$3.12M 0.07% 261

Other funds holding XENT

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Alyeska Investment Group's XENT Position: Q1 2019 in Review

Alyeska Investment Group sold out of Intersect ENT, Inc (XENT) in Q1 2019, closing a stake of 20,386 shares — an estimated $574K sold.

Alyeska Investment Group first reported a position in XENT in Q3 2014 and held it in 3 quarters. The position peaked at $3.21M in Q3 2014. 136 funds tracked by Wall St. Rank hold XENT as of Q1 2019.

  • Alyeska Investment Group reported no remaining Intersect ENT, Inc position as of Q1 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 20,386 Intersect ENT, Inc shares in Q1 2019, an estimated $574K.
  • Alyeska Investment Group first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 3 quarters.
  • Alyeska Investment Group's Intersect ENT, Inc position peaked at $3.21M in Q3 2014.
  • 136 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2019.

Based on Alyeska Investment Group's 13F filing for Q1 2019, filed 15 May 2019.